United Therapeutics (UTHR) Tops Q1 EPS by 7c, Miss on Revenues
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $555.91 +1.60%
EPS Growth %: +11.9%
Financial Fact:
Other, net: 1M
Today's EPS Names:
CRMT, More
EPS Growth %: +11.9%
Financial Fact:
Other, net: 1M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.61, $0.07 better than the analyst estimate of $3.54. Revenue for the quarter came in at $370.5 million versus the consensus estimate of $398.18 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Rivian raises 2026 delivery outlook after Q2 results top guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
